Figure 5From: A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis – the membrane study Pharmacokinetic evaluation (PK-B population; n = 36) at week 8 (V4). Legend: HDF, haemodiafiltration; HDF patients received median dose of 5400 IU.Back to article page